Trial Profile

A phase 3 study of exparel for upper and lower extremity nerve blocks to provide postsurgical analgesia

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 06 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bupivacaine (Primary)
Indications Postoperative pain
Focus Registrational; Therapeutic Use
Sponsors Pacira BioSciences

Most Recent Events

10 Aug 2022 According to a Pacira BioSciences media release, results from the trial are expected in the third and fourth quarters of 2022.
17 Dec 2019 According to Pacira pharmaceuticals media release, this trial is expected to initiate in 2020.
05 Aug 2015 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com